Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clindamycin and colitis: a review.

F J Tedesco

    The Journal of Infectious Diseases
    |March 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Clindamycin can lead to severe pseudomembranous colitis. Prevention involves careful prescription, monitoring for diarrhea, and prompt supportive care to manage this potentially fatal condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The medical bookshelf.

    Postgraduate medicine·2016
    Same author

    Telemedicine: bringing medical care to isolated communities.

    Journal of the Medical Association of Georgia·1993
    Same author

    Management considerations for an HIV positive dental student.

    Journal of dental education·1991
    Same author

    Endoscopic ligation of esophageal varices: an endoscopist's opinion.

    Hepatology (Baltimore, Md.)·1990
    Same author

    Endoscopic therapy for vascular lesions: new challenges.

    Journal of pediatric gastroenterology and nutrition·1988
    Same author

    Differentiating Crohn's colitis from ulcerative colitis. A rundown of likenesses and dissimilarities.

    Postgraduate medicine·1988
    Same journal

    NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

    The Journal of infectious diseases·2026
    Same journal

    Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

    The Journal of infectious diseases·2026
    Same journal

    Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

    The Journal of infectious diseases·2026
    Same journal

    Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

    The Journal of infectious diseases·2026
    Same journal

    Type 3 fimbrial regulation underpins anti-MrkA immunotherapeutic efficacy in experimental Klebsiella pneumoniae infection.

    The Journal of infectious diseases·2026
    Same journal

    Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

    The Journal of infectious diseases·2026
    See all related articles

    Area of Science:

    • Infectious Diseases
    • Gastroenterology
    • Pharmacology

    Background:

    • Clindamycin is an antibiotic frequently associated with severe gastrointestinal side effects.
    • Pseudomembranous colitis is a serious, potentially life-threatening complication linked to clindamycin use.

    Purpose of the Study:

    • To review current strategies for preventing clindamycin-induced pseudomembranous colitis.
    • To highlight the importance of judicious antibiotic selection and early intervention.

    Main Methods:

    • Literature review of studies on clindamycin and pseudomembranous colitis.
    • Analysis of established guidelines for antibiotic use and patient management.

    Main Results:

    • Pseudomembranous colitis is a significant risk associated with clindamycin.

    Related Experiment Videos

  • Effective prevention relies on restricted prescription, early detection of diarrhea, and immediate discontinuation of the antibiotic.
  • Conclusions:

    • Judicious use of clindamycin for severe infections is paramount.
    • Vigilant monitoring for gastrointestinal symptoms and prompt supportive therapy are crucial for mitigating risks.